Lincoln Pharmaceuticals Ltd - 531633 - Shareholding for the Period Ended December 31, 2018
Lincoln Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here Lincoln Pharmaceuticals Ltd - 531633 - Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- MAHENDRA G. PATELDesignation :- Director Results-Financial Results For The Quarter Ended September 30, 2018
we would like to inform that the Board of Directors of the Company at their meeting held today, i.e. on Wednesday, November 14, 2018, has considered and approved the Standalone and Consolidated Un-Audited Financial Results for the Quarter and Half Year Ended on September 30, 2018. Outcome of Board Meeting
we would like to inform that the Board of Directors of the Company at their meeting held today, i.e. on Wednesday, November 14, 2018, has considered and approved the Standalone and Consolidated Un-Audited Financial Results for the Quarter and Half Year Ended on September 30, 2018. Board Meeting Intimation for To Consider And Approve The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half-Year Ended On September 30, 2018 Along With Any Other Business, If Any.
LINCOLN PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2018 ,inter alia, to consider and approve the Un-Audited Standalone and Consolidated Financial Results of the Company for the Quarter and Half-Year Ended on September 30, 2018 along with any other business, if any. Shareholder Meeting-Revised Minutes Of 24Th Annual General Meeting
Revised Minutes of the 24th Annual General Meeting of the Company held at 10:30 A.M. on Saturday, the 29th day of September, 2018 at Registered Office of the Company at ''LINCOLN HOUSE'', Behind Satyam Complex, Science City Road, Sola, Ahmedabad-380060. Shareholder Meeting-Minutes Of 24Th Annual General Meeting
Minutes of the 24th Annual General Meeting of the Company held at 10:30 A.M. on Saturday, the 29th day of September, 2018 at Registered Office of the Company at 'LINCOLN HOUSE', Behind Satyam Complex, Science City Road, Sola, Ahmedabad-380060. Compliance Under Regulation 40 (10) Of SEBI (LODR) Regulations, 2015
Compliance Certificate from PCS regarding Transfer/Transmission/Transposition under Regulation 40 (10) of SEBI (LODR) Regulations, 2015 Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- MAHENDRA G. PATELDesignation :- Director Shareholding for the Period Ended September 30, 2018
Lincoln Pharmaceuticals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here